FDA issues warning to controversial Houston cancer doctor
The Food and Drug Administration has issued a strongly worded warning letter to a controversial Houston physician, Stanislaw Burzynski, who was the subject of a USA TODAY investigation last month. Burzynski – hailed as a maverick by his fans but a snake oil salesman by mainstream doctors -- has long claimed to have dramatic success in hard-to-treat cancers, especially brainstem tumors that are usually considered fatal. According to the National Cancer Institute, however, Burzynski has never produced definitive proof that his drugs save lives by publishing a randomized, controlled trial in a peer-reviewed journal.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Proton Beam Therapy Poised for Growth in US
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'